Ferrari, Ludovica
Ruggiero, Alessandra
Stefani, Chiara
Benedetti, Livia
Piermatteo, Lorenzo
Andreassi, Eleonora
Caldara, Federica
Zace, Drieda
Pagliari, Matteo
Ceccherini-Silberstein, Francesca
Jones, Christopher
Iannetta, Marco
Geretti, Anna Maria http://orcid.org/0000-0002-3670-6588
Ansaldo, Lorenzo
Bertoli, Ada
Bonfante, Francesco
Braccialarghe, Neva
Checchi, Davide
Compagno, Mirko
De Simone, Giuseppe
Geretti, Anna Maria
Grelli, Sandro
Meloni, Diletta
Mulas, Tiziana
Piermatteo, Lorenzo
Sarmati, Loredana
Teti, Elisabetta
,
Funding for this research was provided by:
Roche Diagnostics (EVAN-COV, Prot. n. 659745 - Rep. n. 8020/2022)
Fondo Universitario della Ricerca (FUR2023)
Ministero dell'Università e della Ricerca (MUR 2023/2027)
Article History
Received: 11 December 2023
Accepted: 1 April 2024
First Online: 9 April 2024
Competing interests
: AMG reports personal fees from Abbott, Gilead, GSK, MSD, Roche, and ViiV and research funding (to the institution) from Roche and ViiV for unrelated work. AR reports research funding (to the institution) from Roche for related work. MI reports research funding (to the institution) from Gilead, GSK, and BD Bioscences for unrelated work. Other authors have nothing to disclose.